Lavipharm S.A. (ATH:LAVI)

Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	267	164	134	134	64	30
Market Cap Growth	87.38%	22.01%	0.36%	107.29%	117.58%	23.40%
Enterprise Value	305	191	157	161	98	66
Last Close Price	1.56	0.96	0.76	0.77	0.37	1.56

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	47.66	27.34	14.93	71.42	77.29	17.20
PS Ratio	3.80	2.62	2.53	2.79	1.65	0.75
PB Ratio	4.74	2.90	2.53	3.12	1.60	-2.98
P/TBV Ratio	-	11.22	17.21	78.88	-	-
P/FCF Ratio	-	30.35	-	-	-	13.52
P/OCF Ratio	37.47	24.56	29.82	470.51	19.27	7.21

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	4.33	3.06	2.96	3.36	2.50	1.67
EV/EBITDA Ratio	21.66	14.81	17.69	19.44	19.70	12.35
EV/EBIT Ratio	34.21	22.18	31.17	34.11	24.01	14.66
EV/FCF Ratio	-	35.47	-	-	-	30.17

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.73	0.58	0.64	0.76	0.92	-3.76
Debt / EBITDA Ratio	2.93	2.39	3.53	3.64	6.68	6.28
Debt / FCF Ratio	-	6.08	-	-	-	17.03
Net Debt / Equity Ratio	0.67	0.47	0.54	0.56	0.47	-3.59
Net Debt / EBITDA Ratio	2.84	2.07	3.20	2.91	3.82	6.66
Net Debt / FCF Ratio	-7.54	4.95	-5.51	-6.39	-0.59	16.28
Asset Turnover	0.53	0.49	0.44	0.42	0.47	0.77
Inventory Turnover	1.59	1.49	1.52	1.93	2.18	2.70
Quick Ratio	0.64	0.65	0.56	0.66	0.70	0.35
Current Ratio	1.22	1.21	1.15	1.27	1.00	0.63
Return on Equity (ROE)	10.22%	9.23%	18.10%	4.74%	6.25%	-
Return on Assets (ROA)	4.18%	4.22%	2.62%	2.57%	3.04%	5.46%
Return on Invested Capital (ROIC)	7.41%	7.06%	6.79%	4.58%	4.82%	13.08%
Return on Capital Employed (ROCE)	9.30%	10.00%	5.80%	6.00%	5.90%	38.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.15%	3.66%	6.70%	1.40%	1.29%	5.82%
FCF Yield	-1.87%	3.29%	-3.84%	-2.82%	-50.06%	7.40%
Dividend Yield	1.27%	2.09%	2.62%	-	-	-
Payout Ratio	58.87%	56.48%	-	-	-	-
Buyback Yield / Dilution	-1.66%	0.06%	-0.17%	-681.40%	-26.42%	-
Total Shareholder Return	-0.39%	2.15%	2.44%	-681.40%	-26.42%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 23, 2026

Data Sources Report a data error